The latter is assumed to capture unknown risk factors such as the prevalence of other enterovirus serotypes that could act as partners for recombination and the prevalence of primary immunodeficiencies that might result in prolonged excretion of vaccine poliovirus.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}